Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Delays From Import Alert Highlight Communication, Analytical Testing Issues

This article was originally published in The Tan Sheet

Executive Summary

Firms have yet to prove any of the nearly 50 shipments of vegetable protein concentrates imported from China since April 27 are free of melamine, Dr. David Acheson, FDA's assistant commissioner for food protection, said May 17

You may also be interested in...



Protein, Migrating Ingredients Help Sports Category Build Muscle

Increased consumer demand for protein and the migration of popular ingredients from adjacent categories are spurring growth in sports nutrition. Protein helped drive up sales double digits for powders and formulas and the overall category grew 46% from $17.6 billion in 2006 to $25.7 billion in 2011.

Protein, Migrating Ingredients Help Sports Category Build Muscle

Increased consumer demand for protein and the migration of popular ingredients from adjacent categories are spurring growth in sports nutrition. Protein helped drive up sales double digits for powders and formulas and the overall category grew 46% from $17.6 billion in 2006 to $25.7 billion in 2011.

CFSAN Post May Remain Unfilled Pending Food Safety Legislation Passage

Pending food safety legislation could delay FDA naming a director of the Center for Food Safety and Applied Nutrition, as the anticipated law would bring new responsibilities to the post

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel